SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001821825-23-000006
Filing Date
2023-05-05
Accepted
2023-05-04 18:40:01
Documents
78
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ogn-20230331.htm   iXBRL 10-Q 1386565
2 EX-31.1 ogn03312023-exhibit311.htm EX-31.1 9070
3 EX-31.2 ogn03312023-exhibit312.htm EX-31.2 9219
4 EX-32.1 ogn03312023-exhibit321.htm EX-32.1 7213
5 EX-32.2 ogn03312023-exhibit322.htm EX-32.2 6588
  Complete submission text file 0001821825-23-000006.txt   7111619

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ogn-20230331.xsd EX-101.SCH 50351
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ogn-20230331_cal.xml EX-101.CAL 52755
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ogn-20230331_def.xml EX-101.DEF 225098
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ogn-20230331_lab.xml EX-101.LAB 567131
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ogn-20230331_pre.xml EX-101.PRE 380341
72 EXTRACTED XBRL INSTANCE DOCUMENT ogn-20230331_htm.xml XML 1362793
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Filer) CIK: 0001821825 (see all company filings)

IRS No.: 464838035 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40235 | Film No.: 23890596
SIC: 2834 Pharmaceutical Preparations